1. Home
  2. ATAI vs DSP Comparison

ATAI vs DSP Comparison

Compare ATAI & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • DSP
  • Stock Information
  • Founded
  • ATAI 2018
  • DSP 1999
  • Country
  • ATAI Germany
  • DSP United States
  • Employees
  • ATAI N/A
  • DSP N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • DSP EDP Services
  • Sector
  • ATAI Health Care
  • DSP Technology
  • Exchange
  • ATAI Nasdaq
  • DSP Nasdaq
  • Market Cap
  • ATAI 444.7M
  • DSP 220.3M
  • IPO Year
  • ATAI 2021
  • DSP 2021
  • Fundamental
  • Price
  • ATAI $2.75
  • DSP $13.31
  • Analyst Decision
  • ATAI Strong Buy
  • DSP Strong Buy
  • Analyst Count
  • ATAI 2
  • DSP 8
  • Target Price
  • ATAI $11.00
  • DSP $21.75
  • AVG Volume (30 Days)
  • ATAI 5.3M
  • DSP 248.3K
  • Earning Date
  • ATAI 08-12-2025
  • DSP 08-11-2025
  • Dividend Yield
  • ATAI N/A
  • DSP N/A
  • EPS Growth
  • ATAI N/A
  • DSP N/A
  • EPS
  • ATAI N/A
  • DSP 0.13
  • Revenue
  • ATAI $1,863,000.00
  • DSP $306,484,000.00
  • Revenue This Year
  • ATAI $554.22
  • DSP $18.36
  • Revenue Next Year
  • ATAI N/A
  • DSP $15.95
  • P/E Ratio
  • ATAI N/A
  • DSP $102.81
  • Revenue Growth
  • ATAI 572.56
  • DSP 30.64
  • 52 Week Low
  • ATAI $1.03
  • DSP $8.70
  • 52 Week High
  • ATAI $2.96
  • DSP $26.33
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 67.31
  • DSP 48.13
  • Support Level
  • ATAI $2.15
  • DSP $12.79
  • Resistance Level
  • ATAI $2.29
  • DSP $13.72
  • Average True Range (ATR)
  • ATAI 0.21
  • DSP 0.61
  • MACD
  • ATAI 0.02
  • DSP 0.05
  • Stochastic Oscillator
  • ATAI 78.12
  • DSP 71.13

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: